New Straumann zygomatic implant system for patients with severe jawbone loss in clinical testing

The Straumann Group headquarters is located in Basel in Switzerland. (Image: Straumann)
TextStraumann

BASEL, Switzerland: Zygomatic implants are used in patients with insufficient bone in the posterior upper jaw. As part of its strategy to lead in the area of immediate implants, the Straumann Group has announced a new zygomatic implant solution that it will bring to market in collaboration with Southern Implants.

The new solution combines proven implant design features with the advantages of Straumann’s BLX and BLT implant prosthetic range for fixed overdentures. The system comprises two designs—the Straumann zygomatic implants ZAGA flat and ZAGA round—to cater for differences in bone availability and morphology. It can be used with the Straumann CARES digital workflow to plan the implant position by computer. The novel product will be sold exclusively by Straumann and is currently undergoing clinical evaluation in eight international centres prior to initial market release.

Centres of excellence to increase access to zygomatic implant treatment

Zygomatic implant procedures constitute a niche area because the treatment is complex and requires specialist experience. For this reason, Straumann is working together with leading international surgeons to establish centres of excellence devoted to advancing techniques, sharing knowledge, enhancing skills and training more specialists.